EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE

$450,000U10FY2007CANIH

Frontier Sci & Technology Rsch Fdn, Inc, Boston MA

Investigators

Linked publications & trials

Paper 39491524 Paper 39464610 Paper 39372677 Paper 39122726 Paper 38980029 Paper 38919062 Paper 38744662 Paper 38354784 Paper 38287902 Paper 38235374 Paper 37773489 Paper 37539667 Paper 37375288 Paper 37262321 Paper 36649675 Paper 35538398 Paper 33956343 Paper 30385433 Paper 29980678 Paper 29863451 Paper 29853660 Paper 29475737 Paper 29333527 Paper 29328860 Paper 29138761 Paper 29081880 Paper 28994212 Paper 28931755 Paper 28911092 Paper 28826616 Paper 28691057 Paper 28654365 Paper 28646344 Paper 28579151 Paper 28522460 Paper 28486043 Paper 28334439 Paper 28323331 Paper 28135150 Paper 28068178 Paper 28028022 Paper 27878822 Paper 27870571 Paper 27825638 Paper 27825388 Paper 27780968 Paper 27742794 Paper 27732968 Paper 27695964 Paper 27635620 Paper 27621403 Paper 27618250 Paper 27573652 Paper 27485082 Paper 27468137 Paper 27382098 Paper 27351685 Paper 27264120 Paper 27143689 Paper 27092785 Paper 27044936 Paper 27022111 Paper 26972646 Paper 26970533 Paper 26969090 Paper 26859458 Paper 26755712 Paper 26687819 Paper 26662208 Paper 26625004 Paper 26577691 Paper 26510856 Paper 26493064 Paper 26487588 Paper 26412349 Paper 26371148 Paper 26363982 Paper 26351350 Paper 26351343 Paper 26343802 Paper 26321221 Paper 26307133 Paper 26272427 Paper 26252787 Paper 26244877 Paper 26192408 Paper 26157076 Paper 26138065 Paper 26114161 Paper 26113580 Paper 26111351 Paper 26092816 Paper 26077240 Paper 26077237 Paper 26077235 Paper 26073130 Paper 26056183 Paper 26052356 Paper 26005638 Paper 25985977

Abstract

[unreadable] DESCRIPTION (provided by applicant): This Interim Review application requests funding for those components of the Eastern Cooperative Oncology Group (ECOG) that did not receive full funding for six years at the time of the last competing application. Funding is requested to support the GU and Myeloma Committees, the Leukemia Lab Subcommittee, the Leukemia Core Laboratories, and the ECOG Pathology Coordinating Office through the end of the current competing cycle. [unreadable]

View original record on NIH RePORTER →